Similar Articles |
|
American Family Physician August 1, 2003 Stone et al. |
Off-Label Applications for SSRIs Clinical experience supported by ongoing research continues to expand on the broad array of therapeutic applications for this class of medication. |
Chemistry World July 18, 2012 Andrew Turley |
Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise. |
The Motley Fool June 25, 2010 Brian Orelli |
Mark Your Calendars: Obesity Drugs Take Center Stage Orexigen Therapeutics has been given an FDA advisory committee meeting date, completing the dates for the trio of obesity drugs up for review. |
American Family Physician May 15, 2004 Smucny & Park |
Clinical Inquiries From the Family Practice Inquiries Network: Which antidepressant is best to avoid sexual dysfunction? |
American Family Physician August 1, 2006 Warner et al. |
Antidepressant Discontinuation Syndrome Antidepressant discontinuation syndrome occurs in approximately 20% of patients after abrupt discontinuation of an antidepressant medication that was taken for at least six weeks. |
The Motley Fool June 28, 2010 Luke Timmerman |
Orexigen Drug Shows Potential as "Two-Fer" Against Obesity and Diabetes Orexigen's latest drug aims at treating both diabetes and obesity. |
American Family Physician July 15, 2000 Ethan M. Berke & Nancy E. Morden |
Medical Management of Obesity Family physicians must treat any conditions associated with obesity while working with patients on methods to achieve and maintain weight loss... |
The Motley Fool February 8, 2011 Esterhuizen & Sellitti |
Battle of the Bulge: Biotech Takes on Obesity and Diabetes Will recent advances in pharmaceutical research revolutionize the weight loss industry? It's still early days, but here are some of the stocks to watch. |
Nursing Management March 2012 Yvonne D'Arcy |
Pain and obesity It can be a challenge to provide effective pain management for obese patients; however, a multimodal pain management regimen that combines medications and complementary techniques can help increase pain relief. |
Nurse Practitioner December 2011 |
Managing pain in obese patients Obesity-related pain conditions can limit the patient's efforts at increasing activity and limit quality of life. This article will offer information on these conditions and treatment options. |
American Family Physician November 1, 2005 Steven H. Williams |
Medications for Treating Alcohol Dependence Medications for treating alcohol dependence primarily have been adjunctive interventions, and only three medications -- disulfiram, naltrexone, and acamprosate -- are approved for this indication by the U.S. Food and Drug Administration. |
American Family Physician January 15, 2003 Ables & Baughman |
Antidepressants: Update on New Agents and Indications Many antidepressants have been released in the United States over the past two decades. This article is an update of information about the newer agents for depression and new indications for older antidepressants. |
American Family Physician February 15, 2005 Ham, Waters & Oliver |
Treatment of Panic Disorder Panic disorder with or without agoraphobia occurs commonly in patients in primary care settings. This article assesses multiple evidence-based reviews of effective treatments for panic disorder. |
American Family Physician June 1, 2001 James M. Lyznicki |
Obesity: Assessment and Management in Primary Care Obesity is a complex, multifactorial condition in which excess body fat may put a person at health risk. National data indicate that the prevalence of obesity in the United States is increasing in children and adults... |
American Family Physician March 15, 2003 McInnis et al. |
Counseling for Physical Activity in Overweight and Obese Patients An estimated 97 million adults in the United States, or more than six out of 10 men and women, are overweight or obese. The role of physicians and other health care professionals is associated with greater efforts to help patients adopt healthy lifestyle habits related to diet and exercise. |
The Motley Fool July 16, 2010 Tom Hughes |
Lessons Learned About the Outlook for New Obesity Drug Approval The recent FDA advisory committee meeting on Vivus' weight loss pill proved to us, once again, how incredibly difficult it is to successfully develop and register new drugs for obesity. |
American Family Physician April 15, 2003 Dickerson et al. |
Premenstrual Syndrome Premenstrual syndrome, a common cyclic disorder of young and middle-aged women, is characterized by emotional and physical symptoms that consistently occur during the luteal phase of the menstrual cycle. |
The Motley Fool July 14, 2010 Luke Timmerman |
Vivus Faces Turning Point Tomorrow Thursday's the big day. All eyes will be on Vivus and the FDA's decision on their new obesity drug |
The Motley Fool September 14, 2010 Luke Timmerman |
Arena Obesity Drug Effective by "Slim Margin"; Shares Tumble The market is reacting negatively to news about the company's weight-loss drug. |
Chemistry World June 28, 2012 Patrick Walter |
FDA green lights new obesity drug Lorcaserin, which has been developed by US-based Arena Pharmaceuticals, in conjunction with Japan's Eisai, is the first obesity prescription medicine approved for 13 years. |
The Motley Fool July 13, 2010 Brian Orelli |
A Triple Delight: 3 Stocks All Up More Than 10% What's good for the obese goose is good for the gander when it comes to new drug treatments for losing weight. |
The Motley Fool May 27, 2011 Brian Orelli |
Don't Believe the Obesity Hype Meta-analysis data isn't going to help Arena Pharmaceuticals' obesity drug. |
Chemistry World February 26, 2008 James Mitchell Crow |
Q and A: Do Antidepressants Work? A widely-reported analysis of clinical trial data for Prozac and related antidepressant drugs has claimed that the medicines work little better than chemically-inactive placebos in all but the most severely depressed patients. |
Nursing November 2011 Lawson & Pruitt |
Issues in Obesity, Part 2: Obesity Weighs Heavily on Lung Function A look at the impact of obesity on asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. |
The Motley Fool March 2, 2011 Susmita Chatterjee |
How to Capitalize on the Obesity Epidemic Does broader use of Allergan's Lap-Band signify competition for others? |
Nursing March 2012 Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
American Family Physician August 15, 2002 Ward & Zamorski |
Benefits and Risks of Psychiatric Medications During Pregnancy Decisions regarding the use of psychiatric medications should be individualized, and the most important factor is usually the patient's level of functioning in the past when she was not taking medications. |
Managed Care December 2004 Jack McCain |
The Weight Debate, Continued This article presents the views of people who indulge in what many regard as health care heresy. They challenge the conventional wisdom that millions of Americans need to lose tons of weight, fast, to stave off diabetes, heart disease, cancer. |
AskMen.com July 7, 2014 Patrick Owen |
Is It Impossible To Keep The Weight Off? The world is fatter than ever. In 2010 there were 1.5 billion people worldwide who were obese, and the trend is growing. |
Nurse Practitioner March 2010 Beth Kelsey |
Contraceptive Considerations for Obese Women It is important for nurse practitioners to be equipped with the most up-to-date knowledge to provide evidence-based care individualized to each woman's contraceptive needs and health profile. |
Nursing October 2011 Elizabeth Heavey |
Obesity in pregnancy: Deliver sensitive care This article addresses the health risks of obesity to mother and baby during pregnancy, labor, and delivery and discusses what you can do to mitigate those risks. |
AskMen.com October 13, 2003 Martin Selby |
Obesity: A Bigger Problem Than You Think What are a few extra pounds, after all? Sure, a little extra insulation doesn't hurt, but problems start to arise when your weight crosses that fine line between being overweight and obese. But just what is obesity? And are you at risk? |
Nursing June 2010 Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
American Family Physician November 1, 2006 Lurie et al. |
Seasonal Affective Disorder Patients with seasonal affective disorder have episodes of major depression that tend to recur during specific times of the year, usually in winter. Like major depression, seasonal affective disorder probably is underdiagnosed in primary care settings. |
American Journal of Nursing December 2011 Benton et al. |
Sarcopenic Obesity: Strategies for Management Nurses should be knowledgeable about this condition and its management and routinely educate older patients on the benefits of resistance training and dietary protein to prevent or reverse sarcopenia and sarcopenic obesity. |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
American Family Physician October 15, 2002 Zamorski & Albucher |
What to Do When SSRIs Fail: Eight Strategies for Optimizing Treatment of Panic Disorder Effective management of panic disorder is a common challenge for family physicians. Selective serotonin reuptake inhibitors (SSRIs) are the drugs of choice for this condition because of their safety and efficacy. But not all patients have a favorable response to SSRI therapy. |
The Motley Fool June 3, 2011 Brian Orelli |
FDA Bullies Obesity Drugmakers It's been clear for some time that the Food and Drug Administration isn't particularly fond of obesity drugs. Now it's just being a bully. |
American Family Physician January 1, 2007 Shashi & Subhash Bhatia |
Childhood and Adolescent Depression Safe and effective treatment of major depression in this age group requires accurate diagnosis, suicide risk assessment, and use of evidence-based therapies. |
Chemistry World September 17, 2010 Andrew Turley |
Obesity drugs strive for US approval Could 2010 yet be the year of the obesity drug? At first glance the signs are promising. Regulators in the US will soon decide whether to allow three new contenders onto this attractive market. |
American Family Physician May 15, 2004 Birrer & Vemuri |
Depression in Later Life: A Diagnostic and Therapeutic Challenge Depression in elderly persons is widespread, often undiagnosed, and usually untreated. Because there is no reliable diagnostic test, a careful clinical evaluation is essential. |
BusinessWeek April 26, 2004 Carol Marie Cropper |
A Cloud Over Antidepressants Do some popular drugs cause suicidal behavior in teens? |
Managed Care January 2006 Martin Sipkoff |
Skeptics Abound as Demand Grows For Obesity Treatments Changes in reimbursement patterns for obesity drugs will take several years. Lifestyle changes remain the first approach. |
Nurse Practitioner May 2008 Jarosz & Bellar |
Age-Appropriate Obesity Treatment Older adults who are obese must be assessed and treated for obesity within the context of aging. |
Nurse Practitioner March 2012 Vanya Hamrin et al. |
Evaluation and Management of Pediatric and Adolescent Depression The primary care setting is an appropriate venue for screening and identifying pediatric depression. Nurse practitioners can provide initial management or referral to psychiatric mental health professionals for evidence-based treatments. |
Managed Care November 2007 La Puma & Palmer |
Weight-Loss Programs Need Health Plan Support Weight-loss programs have dismal success rates. Insurers can play an active part in helping members change their thinking, and therefore change their lifestyles |
American Family Physician November 15, 2000 Son & Kirchner |
Depression in Children and Adolescents Depression among children and adolescents is common but frequently unrecognized. It affects 2 percent of prepubertal children and 5 to 8 percent of adolescents... |
Food Processing January 2012 Diane Toops |
Gallup Poll Reveals Americans Reporting Increased Ideal Weight A poll of 1,012 American adults reveals self-reports of weight and average ideal weight have increased over the past 20 years. |
Nursing April 2008 Kathryn Murphy |
Shedding the burden of depression & anxiety Learn about types of depression and available treatments. |
AskMen.com Ross Bonander |
Overcome Social Phobia If you cower under the brutal house lights of social phobia, the good news -- or the bad news -- is that you're not alone. Learn how millions have learned to cope with their disorder. |